Phase II Trial of First-Line Durvalumab and Chemotherapy in Patients With Extra-Pulmonary Small Cell Carcinoma
Peey-Sei Kok, Bryan Chan, Mason Aberoumoud, Alison Zhang et autres
Introduction: Prospective randomized trials are lacking in extensive-stage or metastatic extra-pulmonary small cell carcinoma (EPSCC). As a result, treatment for EPSCC is largely extrapolated from SCLC studies. Methods: This single-arm phase II trial enrolled patients with EPSCC to investigate the activity of …
au (code pays fourni par la source)
0 citations
JTO Clinical and Research Reports